Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if lenalidomide (Revlimid®) can help to
control CLL in patients who have already received standard therapy. The safety of
lenalidomide will also be studied.